Tiaprofenic acid
Clinical data | |
---|---|
Synonyms | 5-Benzoyl-α-methyl-2-thiopheneacetic acid |
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
Pregnancy category |
|
Routes of administration | oral |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | 90% |
Metabolism | 10% hepatic |
Elimination half-life | 1.5-2.5h |
Excretion | 50-80% urine |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C14H12O3S |
Molar mass | 260.309 |
3D model (JSmol) | |
| |
| |
(verify) |
WikiDoc Resources for Tiaprofenic acid |
Articles |
---|
Most recent articles on Tiaprofenic acid Most cited articles on Tiaprofenic acid |
Media |
Powerpoint slides on Tiaprofenic acid |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Tiaprofenic acid at Clinical Trials.gov Trial results on Tiaprofenic acid Clinical Trials on Tiaprofenic acid at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Tiaprofenic acid NICE Guidance on Tiaprofenic acid
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Tiaprofenic acid Discussion groups on Tiaprofenic acid Patient Handouts on Tiaprofenic acid Directions to Hospitals Treating Tiaprofenic acid Risk calculators and risk factors for Tiaprofenic acid
|
Healthcare Provider Resources |
Causes & Risk Factors for Tiaprofenic acid |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Tiaprofenic acid is a non-steroidal anti-inflammatory drug (NSAID) of the arylpropionic acid (profen) class, used to treat pain, especially arthritic pain. The typical adult dose is 300 mg twice daily. It is not recommended in children.
It is sparingly metabolised in the liver to two inactive metabolites. Most of the drug is eliminated unchanged in the urine. Renal disease impairs excretion, and it should be used with caution in renal disease.
Long-term use of tiaprofenic acid is associated with severe cystitis, roughly 100 times more commonly than other NSAIDs.[1] It is contraindicated in patients with cystitis and urinary tract infections.
The earliest reports of clinical use are from France in 1975 [2]
It is marketed under the trade names Surgam, Surgamyl and Tiaprofen, and in generic formulations. A sustained-release preparation is available. It is isomer with Suprofen.
References
- ↑ Crawford MLA, Waller PC, Wood SM (1997). "Severe cystitis associated with tiaprofenic acid". British Journal of Urology. 79 (4): 578–584. doi:10.1046/j.1464-410X.1997.00094.x. PMID 9126086.
- ↑ Pons J, Pasturel A (1975). "[How to improve postoperative complications in stomatological, maxillofacial and plastic surgery: evaluation of tiaprofenic acid]. [French]". Revue d Odonto-Stomatologie. 4 (6 pages = 535-7).
External links
- Pages with script errors
- CS1 maint: Multiple names: authors list
- CS1 maint: Missing pipe
- Template:drugs.com link with non-standard subpage
- Drugs with non-standard legal status
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Infobox drug articles with non-default infobox title
- All articles with dead external links
- Articles with dead external links from November 2011
- Articles with invalid date parameter in template
- Non-steroidal anti-inflammatory drugs
- Drug
- Thiophenes